Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02419716 · ClinicalTrials.gov registry record
A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval
A clinical trial of Colorectal Cancer and Colorectal Cancer Screening, sponsored by Exact Sciences Corporation.
- Completed
- Registry status
- 2,404
- Enrollment target
- 20
- Study locations
NCT02419716: Completed study of Colorectal Cancer and Colorectal Cancer Screening, sponsored by Exact Sciences Corporation.
NCT02419716 is a study of Colorectal Cancer and Colorectal Cancer Screening that has completed, run by Exact Sciences Corporation. The registered enrollment target is 2,404 participants, above the 1,538-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (56% higher). The trial reports 20 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02419716, a study of Colorectal Cancer and Colorectal Cancer Screening, has completed, sponsored by Exact Sciences Corporation.
- COMPLETED
- Registry status
- 2,404 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a prospective longitudinal study to assess the impact of repeat Cologuard testing at 3 years in average risk patients.
Primary Outcome
The difference between the positive predictive value (PPV) at year 3 (PPV3) and 1 minus the negative predictive value (NPV) at year 3 (NPV3).
Conditions Studied
Interventions
- DEVICE Cologuard
Study Locations (20)
California
- Cassidy Medical Group/Radiant Research, Inc. - Carlsbad
- Kindred Medical Institute for Clinical Trials, LLC - Corona
- Paragon Rx Clinical - Garden Grove
- UCLA, Division of Digestive Diseases - Los Angeles
- FACEY Medical Foundation - Mission Hills
- John D. Homan, MD - Newport Beach
- Diverse Research Solutions - Oxnard
- Ventura County Gastroenterology - Oxnard
- Desert Oasis Healthcare Medical Group - Palm Springs
- Advanced Pain Diagnostics & Solutions - Sacramento
Florida
- Innovative Research of West Florida - Clearwater
- Homestead Medical Research - Homestead
- Health Awareness, Inc - Jupiter
- Precision Clinical Research - Lauderdale Lakes
- Advanced Bioresearch - Miami
- Next Phase Research Alliance - Miami
- Clinical Research Center of Florida - Pompano Beach
Arizona
- Thomas C Lenzmeier, M.D., P.C - Glendale
- Central Arizona Medical Associates, PC - Mesa
- Fiel Family and Sports Medicine - Tempe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,404 participants |
| Start Date | 2015-04 |
| Est. Completion | 2020-03-16 |
What the finished NCT02419716 record still lists
NCT02419716 is an observational study that tracks outcomes without assigning an intervention. Its 2,404 participants enrollment target places it among the larger protocols in the corpus, above the 1,538-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (56% higher).
The record links to 2 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Cologuard is the first listed.
NCT02419716 names 20 study sites across 3 states, led by California, Florida, Arizona.
Frequently Asked Questions
What is clinical trial NCT02419716 about?
NCT02419716 is a clinical study titled "A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval". This is a prospective longitudinal study to assess the impact of repeat Cologuard testing at 3 years in average risk patients.
What is the current status of trial NCT02419716?
This trial is currently completed. The enrollment target is 2,404 participants. The study started on 2015-04. Estimated completion is 2020-03-16.
What conditions does trial NCT02419716 study?
This clinical trial studies the following conditions: Colorectal Cancer, Colorectal Cancer Screening.
What interventions are being tested in trial NCT02419716?
The interventions under investigation include: Cologuard (DEVICE).
Who is sponsoring clinical trial NCT02419716?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02419716 being conducted?
This trial has 20 study locations across Arizona, California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02419716's enrollment target sits among peer trials
2,404 27th of 381 higher than 354 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05185440 · 2,400 participants · NA
Reducing Alcohol Involved Sexual Violence in Higher Education
- NCT05285527 · 2,400 participants · NA
MiSight 1 Day Safety Post-Approval Study
- NCT05738330 · 2,400 participants · NA
Symptom Monitoring in Hemodialysis
- NCT05833360 · 2,400 participants
Prospective Study of oncRNA Stratification of Cancer by Size and Stage
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia